Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “t(11;14) Positive”

6 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 6 of 6 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07335887
What this trial is testing

Sonrotoclax Plus Dexamethasone With or Without Daratumumab Regimen in Patients With t(11;14) Primary AL Amyloidosis

Who this might be right for
AL Amyloidosis (AL)t(11;14) Positive
Peking University People's Hospital 39
Testing effectiveness (Phase 2)Active Not RecruitingNCT03872180
What this trial is testing

Bendamustine, Obinutuzumab, and Venetoclax in Patients With Untreated Mantle Cell Lymphoma

Who this might be right for
CCND1 PositiveMantle Cell Lymphomat(11;14) Positive
Emory University 23
Testing effectiveness (Phase 2)Active Not RecruitingNCT03946878
What this trial is testing

Venetoclax and Acalabrutinib in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma

Who this might be right for
Blastoid Variant Mantle Cell LymphomaCCND1 Protein OverexpressionCD20 Positive+6 more
M.D. Anderson Cancer Center 32
Testing effectiveness (Phase 2)Looking for participantsNCT05530421
What this trial is testing

Selinexor, Venetoclax, and Dexamethasone (XVenD) in t(11;14)-Positive Relapsed/Refractory Multiple Myeloma

Who this might be right for
Relapsed and Refractory Multiple Myeloma
University of Miami 33
Testing effectiveness (Phase 2)WithdrawnNCT03785184
What this trial is testing

Venetoclax Plus Lenalidomide and Dexamethasone for the Treatment of Newly Diagnosed t(11;14)-Positive Multiple Myeloma in Subjects Who Are Ineligible for High-Dose Therapy

Who this might be right for
Multiple Myeloma
AbbVie
Large-scale testing (Phase 3)Active Not RecruitingNCT03539744
What this trial is testing

A Study Designed to Evaluate the Safety and Efficacy of Venetoclax Plus Dexamethasone (VenDex) Compared With Pomalidomide Plus Dexamethasone (PomDex) in Participants With t(11;14)-Positive Relapsed or Refractory Multiple Myeloma.

Who this might be right for
Multiple Myeloma
AbbVie 265